title: Hydroxyurea use and hospitalization trends in a comprehensive pediatric sickle cell program.
abstract: BACKGROUND
  A decline in hospitalizations and pain episodes among those with sickle cell disease (SCD) who take hydroxyurea (HU) has been shown when compared to pre-HU patterns but paradoxically, when compared to those who have never been treated, HU recipients often have more frequent hospitalizations. This analysis evaluates the impact of increasing usage of HU on trends in hospitalizations and blood transfusions within a large SCD treatment program.
  
  
  METHODS
  Eligibility was restricted to patients with Hb SS or Hb Sβ⁰-thalassemia who were 2-18 years old between 2006-2010 and received care at St. Jude Children's Research Hospital (N = 508). Hospitalizations and blood transfusions were calculated for each of the years under study for those exposed and never exposed to HU. Differences in number of hospitalizations before and after HU initiation were compared.
  
  
  RESULTS
  The proportion of patients receiving HU increased by 4% per year on average. In the HU exposed group, a modest decline in mean per-patient hospitalizations and per-patient hospital days occurred, while those never exposed to HU trended toward a slight increase over time. Rates of blood transfusions declined among those on HU but not in patients never exposed to HU. Patients on HU had a median of one fewer hospital admission in the year after initiation of HU, compared to the year prior. Two deaths occurred in the patient population, both of whom were not exposed to HU.
  
  
  CONCLUSIONS
  Increasing usage of HU was concurrent with decreased hospitalization rates and blood transfusions. Our results support the utility of HU on decreasing hospitalizations and transfusions for patients with SCD outside of the clinical trial setting.
authors: Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America. kerri.nottage@stjude.org
authors: Kerri A
authors: KA
authors: Nottage
authors: Jane S
authors: JS
authors: Hankins
authors: Matthew
authors: M
authors: Smeltzer
authors: Fawaz
authors: F
authors: Mzayek
authors: Winfred C
authors: WC
authors: Wang
authors: Banu
authors: B
authors: Aygun
authors: James G
authors: JG
authors: Gurney
mesh_terms: D000293:Adolescent; D000755:Anemia, Sickle Cell / Q000188:drug therapy* / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D017707:Erythrocyte Transfusion; D005260:Female; D006760:Hospitalization / Q000639:trends*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D008297:Male
chemical_list: D006918:Hydroxyurea
references: J Health Care Poor Underserved. 2010 Feb;21(1):277-86
references: 20173269
references: J Natl Med Assoc. 2008 Aug;100(8):968-73
references: 18717150
references: Ann Intern Med. 2008 Jun 17;148(12):932-8
references: 18458271
references: Am J Hematol. 2005 Jun;79(2):107-13
references: 15929107
references: Am J Hematol. 2009 Jun;84(6):323-7
references: 19358302
references: Am J Hematol. 2010 Aug;85(8):611-3
references: 20658592
references: Hematol Oncol Clin North Am. 2010 Feb;24(1):199-214
references: 20113903
references: Pediatr Blood Cancer. 2012 Apr;58(4):584-90
references: 21584938
references: Am J Hematol. 2010 Oct;85(10):795-7
references: 20645429
references: Public Health Rep. 1997 Jan-Feb;112(1):44-51
references: 9018288
references: Public Health Rep. 1995 Jan-Feb;110(1):80-6
references: 7838948
references: Am J Hematol. 2006 Dec;81(12):927-32
references: 16924648
references: Pediatr Clin North Am. 2008 Apr;55(2):483-501, x
references: 18381097
references: Blood. 1999 Sep 1;94(5):1550-4
references: 10477679
references: Lancet. 2011 May 14;377(9778):1663-72
references: 21571150
references: J Pediatr Hematol Oncol. 1999 Sep-Oct;21(5):389-96
references: 10524452
references: Am J Prev Med. 2010 Apr;38(4 Suppl):S550-6
references: 20331957
references: Pediatr Blood Cancer. 2009 Oct;53(4):642-6
references: 19492318
references: Blood. 2004 Mar 15;103(6):2039-45
references: 14630791
references: N Engl J Med. 1995 May 18;332(20):1317-22
references: 7715639